Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer
Clinical trial NCT01471964 · TERMINATED
Trial details
- NCT number
- NCT01471964
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-20
- Primary completion
- 2017-02-07
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.